 Uveal Neoplasms
"Uveal Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the UVEA.
| Descriptor ID |
D014604
|
| MeSH Number(s) |
C04.588.364.978 C11.319.494 C11.941.855
|
| Concept/Terms |
Uveal Neoplasms- Uveal Neoplasms
- Neoplasm, Uveal
- Neoplasms, Uveal
- Uveal Neoplasm
|
Below are MeSH descriptors whose meaning is more general than "Uveal Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Uveal Neoplasms".
This graph shows the total number of publications written about "Uveal Neoplasms" by people in this website by year, and whether "Uveal Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 1 | 0 | 1 | | 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Uveal Neoplasms" by people in Profiles.
-
Mukherjee N, Dart CR, Amato CM, Honig-Frand A, Lambert JR, Lambert KA, Robinson WA, Tobin RP, McCarter MD, Couts KL, Fujita M, Norris DA, Shellman YG. Expression Differences in BCL2 Family Members between Uveal and Cutaneous Melanomas Account for Varying Sensitivity to BH3 Mimetics. J Invest Dermatol. 2022 07; 142(7):1912-1922.e7.
-
Bravo-Filho V, Logan P, Zoroquiain P, Aldrees S, Vil? N, Oweida A, Belfort Neto R, Burnier MN. Effects of ranibizumab and amfenac on the functional abilities and radiosensitivity of uveal melanoma cells. Arq Bras Oftalmol. 2019 Jan-Feb; 82(1):38-44.
-
Javed A, Arguello D, Johnston C, Gatalica Z, Terai M, Weight RM, Orloff M, Mastrangelo MJ, Sato T. PD-L1 expression in tumor metastasis is different between uveal melanoma and cutaneous melanoma. Immunotherapy. 2017 12; 9(16):1323-1330.
-
Falchook GS, Lewis KD, Infante JR, Gordon MS, Vogelzang NJ, DeMarini DJ, Sun P, Moy C, Szabo SA, Roadcap LT, Peddareddigari VG, Lebowitz PF, Le NT, Burris HA, Messersmith WA, O'Dwyer PJ, Kim KB, Flaherty K, Bendell JC, Gonzalez R, Kurzrock R, Fecher LA. Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial. Lancet Oncol. 2012 Aug; 13(8):782-9.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|